Redeye: Proact IT Group - Improvement measures paying off

Redeye remains positive on Proact following a rebound in BU West and optimistic comments regarding April. We increase our EBITA forecasts for 2020 and 2021 by 23% and 5%. We find the current valuation of EV/EBITA 5.8x 2021E attractive and raise our Base case.

Read more and download the research update: https://bit.ly/2VGN6Lo

Start following companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/